1. Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature. (August 2021) Authors: Piña, Yolanda; Evernden, Brittany R.; Khushalani, Nikhil; Margolin, Kim; Tawbi, Hussein; Tran, Nam D.; Macaulay, Robert; Forsyth, Peter; Peguero, Edwin Journal: SAGE open medical case reports Issue: Volume 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM. (12th November 2021) Authors: Pina, yolanda; Mokhtari, Sepideh; Kim, Youngchul; Evernden, Brittany; Tran, Nam; Smalley, Inna; Khushalani, Nikhil; Law, Vincent; Puskas, John; Caseres, Gisela; Vogelbaum, Michael; Smalley, Keiran; Peguero, Edwin; Forsyth, Peter Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BRAF Inhibitor Therapy-Related Encephalitis in a Patient with Metastatic Melanoma. (17th July 2021) Authors: Babacan, Nalan Akgul; Peguero, Edwin; Forsyth, Peter; Eroglu, Zeynep Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF Inhibitor Therapy‐Related Encephalitis in a Patient with Metastatic Melanoma. (17th July 2021) Authors: Babacan, Nalan Akgul; Peguero, Edwin; Forsyth, Peter; Eroglu, Zeynep Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CNSC-03. NEURONAL INTERMEDIATE FILAMENT (NIF) ANTIBODY POSITIVE PARANEOPLASTIC SYNDROME IN A PATIENT WITH METASTATIC NEUROENDOCRINE PANCREATIC CARCINOMA AND TREATMENT WITH IPILIMUMAB/NIVOLUMAB. (14th November 2022) Authors: Rodriguez, Karla Mora; Peguero, Edwin; Pina, Yolanda; Strosberg, Jonathan; Verma, Neha; Mokhtari, Sepideh Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas. (1st September 2021) Authors: Fusco, Michael J.; Piña, Yolanda; Macaulay, Robert J.; Sahebjam, Solmaz; Forsyth, Peter A.; Peguero, Edwin; Walko, Christine M. Journal: Cancer control Issue: Volume 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dyskinesia during concomitant usage of phenytoin and capecitabine. Issue 1152 (7th August 2020) Authors: Keerty, Dinesh; Kessler, Rene; Koverzhenko, Viktoriya; Peguero, Edwin Journal: Postgraduate medical journal Issue: Volume 97:Issue 1152(2021) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. (December 2020) Authors: Jaffer, Muhammad; Chung, Matthew; Sharda, Esha; Ramsakal, Asha; Peguero, Edwin; Verma, Neha; Mokhtari, Sepideh Journal: Clinical medicine insights. Oncology Issue: Volume 14(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma. Issue 9 (November 2018) Authors: Maller, Bradley; Peguero, Edwin; Tanvetyanon, Tawee Journal: Journal of immunotherapy Issue: Volume 41:Issue 9(2018:Nov./Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. NCMP-05. RITUXIMAB AS INITIAL THERAPY FOR THE REVERSAL OF MYASTHENIA GRAVIS NEUROTOXICITY CAUSED BY IPILIMUMAB/NIVOLUMAB. (5th November 2018) Authors: Verma, Neha; Jaffer, Muhammed; Peguero, Edwin; Mokhtari, Sepideh Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗